🔗 Permalink

Inventor profile of:

Mark Parrington

City:

Bradford

Country:

Canada

Published Applications:

Last publication date:

2013-09-19

Top Assignees for applications by Mark Parrington

The entities that hold a legal rights for patent applications filed by inventor Parrington Mark:

Sanofi Pasteur Limited 7 Toronto, Ontario, Canada
AVENTIS PASTEUR, INC. 2 Swiftwater, PA United States
Sanofi Pasteur Limited 1 Toronto, Canada
Sanofi Pasteur Biologics Co. 1 Cambridge, MA United States
THERION BIOLOGICS, INC. 1 Boston, MA United States
Aventis Pasteur Ltd 1 Toronto, Canada
Sanofi Pasteur Biologics, LLC 1 Cambridge, MA United States
Sanofi Pasteur Limited 1 North York, Ontario, Canada
SANOFI PASTEUR LIMITED 1 Toronto, ON Canada

Recent patent applications by Parrington Mark

Mark Parrington from Bradford, CA has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2013-09-19

US20130243812A1

Chemistry; metallurgy

Replication-defective flavivirus vaccines and vaccine vectors

#2 | 2013-04-25

US20130101625A1

Human necessities

Modified CEA nucleic acid and expression vectors

#3 | 2013-01-10

US20130011422A1

Chemistry; metallurgy

Tumor Antigens for the Prevention and/or Treatment of Cancer

#4 | 2012-05-24

US20120128713A1

Human necessities

Replication-Defective Flavivirus Vaccine Vectors Against Respiratory Syncytial Virus

#5 | 2011-05-19

US20110117640A1

Chemistry; metallurgy

Tumor antigens BFA4 and BCY1 for prevention and / or treatment of cancer

#6 | 2010-12-14

US10611440

Tumor antigens BFA4 and BCY1 for prevention and / or treatment of cancer

#7 | 2010-11-11

US20100285065A1

Human necessities

Modified CEA nucleic acid and expression vectors

#8 | 2010-11-04

US20100278848A1

Chemistry; metallurgy

Tumor antigens for prevention and/or treatment of cancer

#9 | 2009-06-18

US20090156519A1

Human necessities

Modified KSA and Uses Thereof

#10 | 2008-06-12

US20080138365A1

Chemistry; metallurgy

Tumor antigens Bfa5 for prevention and/or treatment of cancer

#11 | 2008-05-15

US20080113928A1

Chemistry; metallurgy

Modified CEA/B7 vector

#12 | 2007-05-22

US9914205

Expressing gp140 fragment of primary HIV-1 isolate

#13 | 2007-04-12

US20070082391A1

Chemistry; metallurgy

Modified CEA nucleic acid and expression vectors

#14 | 2006-06-15

US20060127360A1

Physics

Multi-antigen vectors of melanoma

#15 | 2005-05-26

US20050112099A1

Chemistry; metallurgy

Tumor antigen BFA5 for prevention and / or treatment of cancer

#16 | 2005-02-17

US20050037015A1

Human necessities

Immunogenic compositions comprising an antigen and a purified m protein from respiratory syncytial virus

InventorID:

27132 ⎘